Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
12.66
-0.13 (-1.02%)
Nov 6, 2026, 3:04 PM CST
SHE:002755 Market Cap
SHE:002755 has a market cap or net worth of 11.75 billion as of November 6, 2026. It is the 7,066th most valuable company in the world and the 1,349th biggest in China. Its market cap has decreased by 33.54% in one year.
Market Cap
11.75B
Enterprise Value
9.43B
Revenue
1.59B
Global Rank
Country Rank
#1,349 China
PE Ratio
66.14
ChartMarket Cap Chart
Since January 2, 2019, SHE:002755's market cap has increased from 9.84B to 11.75B, an increase of 19.44%. That is a compound annual growth rate of 2.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 11.75B | -22.47% |
| Dec 31, 2025 | 15.16B | 28.48% |
| Dec 31, 2024 | 11.80B | 17.47% |
| Dec 29, 2023 | 10.04B | 36.27% |
| Dec 30, 2022 | 7.37B | -37.63% |
| Dec 31, 2021 | 11.82B | -2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.85B |
| Fujian Cosunter Pharmaceutical | 12.72B |
| Shenzhen Hepalink Pharmaceutical Group | 12.52B |
| Guobang Pharma | 12.11B |
| Shanghai Shyndec Pharmaceutical | 11.12B |
| Zhuhai Trinomab Pharmaceutical | 11.08B |
| Yantai Dongcheng Pharmaceutical Group | 10.87B |
| Zhejiang CONBA Pharmaceutical | 10.82B |